Evidence map›Paper›PMID 21467203›Full record

ArticleHuman reproduction (Oxford, England)2011

Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis.

J K Kline, A M Kinney, B Levin, A C Kelly, M Ferin, D Warburton

Open access · bronzeAbstract read
In one paragraph

Article in Human reproduction (Oxford, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Ovarian reserve testing: assessing oocyte quantity and quality.Journal of assisted reproduction and genetics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J K KlineImprints Center, New York State Psychiatric Institute, New York, NY 10032, USA. jkk3@columbia.edu
A M Kinney
B Levin
A C Kelly
M Ferin
D Warburton
Columbia University · US

Funding

Skewed X Inactivation and Reproductive LossR01HD042745 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WARBURTON, DOROTHY P. · 2002 to 2006
$2.3M
EPIDEMIOLOGY OF TRISOMY AND OVARIAN AGER01AG015386 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE · PI KLINE, JENNIE KATHERINE · 1998 to 2003
$1.2M
Trisomy and ovarian age: An epidemiologic studyR01HD053814 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KLINE, JENNIE KATHERINE · 2008 to 2010
$1.0M
NIA NIH HHS R01 AG 15386NICHD NIH HHS R01 HD042745NICHD NIH HHS R01 HD053814NICHD NIH HHS R01 HD 053814-01A2NICHD NIH HHS R01 HD 42725
6 · The paper itself

Abstract

backgroundSome studies, but not all, support the hypothesis that trisomy frequency is related to the size of the oocyte pool, with the risk increased for women with fewer oocytes (older ovarian age). We tested this hypothesis by comparing hormonal indicators of ovarian age among women who had trisomic pregnancy losses with indicators among women with non-trisomic losses or chromosomally normal births. The three primary indicators of advanced ovarian age were low level of anti-Müllerian hormone (AMH), high level of follicle-stimulating hormone (FSH) and low level of inhibin B.

methodsThe analysis drew on data from two hospital-based case-control studies. Data were analyzed separately and the evidence from the two sites was combined. We compared 159 women with trisomic pregnancy losses to three comparison groups: 60 women with other chromosomally abnormal losses, 79 women with chromosomally normal losses and 344 women with live births (LBs) age-matched to women with losses. We analyzed the hormone measures as continuous and as categorical variables. All analyses adjust for age in single years, day of blood draw, interval in storage and site.

resultsAMH and inhibin B did not differ between women with trisomic losses and any of the three comparison groups. Mean ln(FSH) was 0.137 units (95% confidence interval (CI): 0.055, 0.219) higher for trisomy cases compared with LB controls; it was also higher, though not significantly so, for trisomy cases compared with women with other chromosomally abnormal losses or chromosomally normal losses. The adjusted odds ratio in relation to high FSH (≥ 10 mIU/ml) was significantly increased for trisomy cases versus LB controls (adjusted odds ratio (OR): 3.8, 95% CI: 1.6, 8.9).

conclusionsThe association of trisomy with elevated FSH is compatible with the oocyte pool hypothesis, whereas the absence of an association with AMH is not. Alternative interpretations are considered, including the possibility that elevated FSH may disrupt meiotic processes or allow recruitment of abnormal follicles.

Indexed as

AneuploidyTrisomyAdultAnti-Mullerian HormoneCase-Control StudiesFemaleFollicle Stimulating HormoneHumansInhibinsMaternal AgeOocytesOvaryPregnancyPregnancy ComplicationsAnti-Mullerian HormoneFollicle Stimulating Hormoneinhibin BInhibins

Identifiers

PMID21467203
PMCPMC3140264
OpenAlexW2119889599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.